SEC Form 4 · accession 0001127602-19-007870
MERIDIAN BIOSCIENCE INC · VIVO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lourdes Weltzien
Officer — EVP, Life Science
Period of report
Nov 21, 2018
Accepted (ET)
Feb 25, 2019 · 9:41 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000794172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 21, 2018 | F | 158 | $18.14 | D | 48,419 | D |
Table II — derivative securities
No Table II lines on this filing.